Cargando…
Ocular findings in 22q11.2 deletion syndrome: A systematic literature review and results of a Dutch multicenter study
The 22q11.2 deletion syndrome (22q11.2DS) is a multisystem disorder with an estimated prevalence of 1:3000 live births. Manifestations show a marked variability in expression and include speech‐ and language delay, intellectual disability, and neuropsychiatric disorders. We aim to provide an overvie...
Autores principales: | von Scheibler, Emma N. M. M., van der Valk Bouman, Emy S., Nuijts, Myrthe A., Bauer, Noël J. C., Berendschot, Tos T. J. M., Vermeltfoort, Pit, Bok, Levinus A., van Eeghen, Agnies M., Houben, Michiel L., van Amelsvoort, Thérèse A. M. J., Boot, Erik, van Egmond‐Ebbeling, Michelle B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298823/ https://www.ncbi.nlm.nih.gov/pubmed/34773366 http://dx.doi.org/10.1002/ajmg.a.62556 |
Ejemplares similares
-
Post-traumatic stress in adults with 22q11.2 deletion syndrome
por: von Scheibler, Emma N. M. M., et al.
Publicado: (2022) -
Intellectual and Behavioral Phenotypes of Smith–Magenis Syndrome: Comparisons between Individuals with a 17p11.2 Deletion and Pathogenic RAI1 Variant
por: Linders, Cathelijne C., et al.
Publicado: (2023) -
Parkinsonism in Genetic Neurodevelopmental Disorders: A Systematic Review
por: von Scheibler, Emma N.M.M., et al.
Publicado: (2022) -
Possible underreporting of pathogenic variants in
RAI1
causing Smith–Magenis syndrome
por: Boot, Erik, et al.
Publicado: (2021) -
Adverse effects of antipsychotic medication in patients with 22q11.2 deletion syndrome: A systematic review
por: de Boer, Janna, et al.
Publicado: (2019)